Regulatory Endpoints

Regulatory Endpoints is a formal measure or observation used in pharmacological studies to assess the safety, efficacy, quality, or risk-benefit profile of a drug or biologic for regulatory decision-making.

17

Publications

586

Citations

69

Authors

37

Institutions

Publications per year

2017–2026

9

Authors

69

  1. RS
    Robert S. Schulz

    University of Koblenz and Landau, Germany

    2 publications · 42 citations

    2

    h-index

  2. OA
    Osarobo Awanbor

    University of Koblenz and Landau, Germany

    2 publications · 42 citations

    2

    h-index

  3. PU
    Philipp Uhl

    University of Koblenz and Landau, Germany

    2 publications · 42 citations

    2

    h-index

  4. CA
    Carsten A. Brühl

    University of Koblenz and Landau, Germany

    2 publications · 42 citations

    2

    h-index

  5. JO
    Julian Oliver

    Louisiana State University, United States

    1 publications · 26 citations

    1

    h-index

1–5 of 69

Venues

  1. Toxicologic Pathology

    1 publications · 26 citations

    2

    h-index

  2. Clinical Gastroenterology and Hepatology

    CGH · 1 publications · 46 citations

    1

    h-index

  3. PLoS ONE

    1 publications · 32 citations

    1

    h-index

  4. MDM Policy & Practice

    1 publications · 14 citations

    1

    h-index

  5. Toxicology Letters

    1 publications · 10 citations

    1

    h-index

1–5